Comparison of the use and non-use of Fosamax in men and women.

Under similar conditions (characteristics, BMD differences, and cumulative use of immunosuppressive agents) the use of Fosamax in male patients increased the BMD of both lumbar spine and hip bone, but in female patients it increased the BMD only of lumbar spine.NS*: p>0.05 between male and female patients.Abbreviations: LS-BMD, lumbar spine bone mineral density; H-BMD, hip bone mineral density; FN-BMD, femoral neck bone mineral density;NS, no significance, p>0.05.